Latest Breaking News On - சின்வெனியோ உயிர் அமைப்புகள் இன்க் - Page 1 : comparemela.com

Cell Free Dna Testing Market Grows With Changing Consumer Preferences & New Opportunities Global cell-free DNA testing market was valued US$ 85.3 Mn in 2017 and is expected to reach US$ 439.2 Mn by 2026, at a CAGR of 22.73 % during a forecast period. BriefingWire.com, 5/04/2021 - Global cell-free DNA testing market was valued US$ 85.3 Mn in 2017 and is expected to reach US$ 439.2 Mn by 2026, at a CAGR of 22.73 % during a forecast period. Cell-free DNA (cfDNA) is also called NIPT. The non-invasive prenatal test is a new technology being used to assess the risk of a pregnant woman s and taking a sample of blood from the vein rather than inserting a needle into the uterus similar to amniocentesis. The cell-free DNA testing is used in many fields such as gynecology, oncology, and transplantation to identify mutations in cancer patients and identify various chromosomal abnormalities in the fetus, to know the gender of the fetus. Incr

United statesCirculogene theranosticsFoundation medicineBiocept incCynvenio biosystems incBiodesix incGuardant health incIllumina incLaboratory corpCounsyl incCaredx incBerry genomics coGet sample premium reportFor report discountsFor report descriptionBerry genomics